Parallel

Parallel is a company striving to redefine well-being in a whole new paradigm. They recognize the global human desire for natural alternatives to enhance personal best, leading them to natural cannabinoid products. Through their proprietary brands, Parallel is dedicated to elevating consumer well-being while maintaining a focus on future innovation and high business standards. The company's diverse portfolio covers the full spectrum of well-being, addressing recovery, relief, rest, and revelry. Founded in 2014, Parallel is committed to helping consumers lead intentional lives with the best cannabinoid products. The company's vision is centered on the Health Care and Health and Wellness industries, reflecting a deep understanding of the market's needs. Their recent Debt Financing investment at 08 December 2022 underscores investor confidence in their mission. Despite the lack of specific investor details, this injection of capital positions Parallel for continued growth and innovation. The company's slogan, "Welcome to a whole new paradigm of well-being," encapsulates their commitment to improving consumer well-being through natural cannabinoid products, backed by the promise of ongoing scientific, technological, and R&D advancements. Parallel's dedication to high-quality, safe, and effective products aligns with current market trends and bodes well for their future success.